These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8929560)

  • 1. His-X-X-X-His motif in S100 protein, calprotectin: relation to microbiostatic activity.
    Clohessy PA; Golden BE
    J Leukoc Biol; 1996 Nov; 60(5):674. PubMed ID: 8929560
    [No Abstract]   [Full Text] [Related]  

  • 2. Calprotectin-mediated zinc chelation as a biostatic mechanism in host defence.
    Clohessy PA; Golden BE
    Scand J Immunol; 1995 Nov; 42(5):551-6. PubMed ID: 7481561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zinc-reversible antimicrobial activity of recombinant calprotectin (migration inhibitory factor-related proteins 8 and 14).
    Sohnle PG; Hunter MJ; Hahn B; Chazin WJ
    J Infect Dis; 2000 Oct; 182(4):1272-5. PubMed ID: 10979933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histidine-based zinc-binding sequences and the antimicrobial activity of calprotectin.
    Loomans HJ; Hahn BL; Li QQ; Phadnis SH; Sohnle PG
    J Infect Dis; 1998 Mar; 177(3):812-4. PubMed ID: 9498472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mechanism of calprotectin's candidastatic activity appears to involve zinc chelation.
    Clohessy PA; Golden BE
    Biochem Soc Trans; 1996 May; 24(2):309S. PubMed ID: 8736967
    [No Abstract]   [Full Text] [Related]  

  • 6. Microbiostatic activity of human plasma and its relation to zinc and iron availability.
    Clohessy PA; Golden BE
    Biochem Soc Trans; 1996 May; 24(2):311S. PubMed ID: 8736969
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-Candida activity of calprotectin in combination with neutrophils or lactoferrin.
    Okutomi T; Tanaka T; Yui S; Mikami M; Yamazaki M; Abe S; Yamaguchi H
    Microbiol Immunol; 1998; 42(11):789-93. PubMed ID: 9886152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional and clinical aspects of the myelomonocyte protein calprotectin.
    Johne B; Fagerhol MK; Lyberg T; Prydz H; Brandtzaeg P; Naess-Andresen CF; Dale I
    Mol Pathol; 1997 Jun; 50(3):113-23. PubMed ID: 9292145
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro candidastatic properties of the human neutrophil calprotectin complex.
    Murthy AR; Lehrer RI; Harwig SS; Miyasaki KT
    J Immunol; 1993 Dec; 151(11):6291-301. PubMed ID: 8245468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppressive activity of lycoricidinol (narciclasine) against cytotoxicity of neutrophil-derived calprotectin, and its suppressive effect on rat adjuvant arthritis model.
    Mikami M; Kitahara M; Kitano M; Ariki Y; Mimaki Y; Sashida Y; Yamazaki M; Yui S
    Biol Pharm Bull; 1999 Jul; 22(7):674-8. PubMed ID: 10443460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial activity of calprotectin isolated from human empyema fluid supernatants.
    Santhanagopalan V; Hahn BL; Dunn BE; Weissner JH; Sohnle PG
    Clin Immunol Immunopathol; 1995 Sep; 76(3 Pt 1):285-90. PubMed ID: 7554450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The leucocyte protein L1 (calprotectin): a putative nonspecific defence factor at epithelial surfaces.
    Brandtzaeg P; Gabrielsen TO; Dale I; Müller F; Steinbakk M; Fagerhol MK
    Adv Exp Med Biol; 1995; 371A():201-6. PubMed ID: 8525906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of apoptotic cell death in mouse lymphoma and human leukemia cell lines by a calcium-binding protein complex, calprotectin, derived from inflammatory peritoneal exudate cells.
    Yui S; Mikami M; Yamazaki M
    J Leukoc Biol; 1995 Dec; 58(6):650-8. PubMed ID: 7499962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Candida albicans growth by calprotectin in the absence of direct contact with the organisms.
    Sohnle PG; Hahn BL; Santhanagopalan V
    J Infect Dis; 1996 Dec; 174(6):1369-72. PubMed ID: 8940237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Host-parasite interaction in human onchocerciasis: identification and sequence analysis of a novel human calgranulin.
    Marti T; Erttmann KD; Gallin MY
    Biochem Biophys Res Commun; 1996 Apr; 221(2):454-8. PubMed ID: 8619876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth-inhibitory and apoptosis-inducing activities of calprotectin derived from inflammatory exudate cells on normal fibroblasts: regulation by metal ions.
    Yui S; Mikami M; Tsurumaki K; Yamazaki M
    J Leukoc Biol; 1997 Jan; 61(1):50-7. PubMed ID: 9000536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural and functional evolution of the L1 family: are four adhesion molecules better than one?
    Hortsch M
    Mol Cell Neurosci; 2000 Jan; 15(1):1-10. PubMed ID: 10662501
    [No Abstract]   [Full Text] [Related]  

  • 18. Restoration of anti-Aspergillus defense by neutrophil extracellular traps in human chronic granulomatous disease after gene therapy is calprotectin-dependent.
    Bianchi M; Niemiec MJ; Siler U; Urban CF; Reichenbach J
    J Allergy Clin Immunol; 2011 May; 127(5):1243-52.e7. PubMed ID: 21376380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calprotectin and lactoferrin levels in the gingival crevicular fluid of children.
    Miyasaki KT; Voganatsi A; Huynh T; Marcus M; Underwood S
    J Periodontol; 1998 Aug; 69(8):879-83. PubMed ID: 9736370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies to calprotectin are not found in patients with systemic lupus erythematosus or other inflammatory rheumatic diseases.
    Wahren M; Brun JG; Jonsson R; Haga HJ
    Lupus; 1995 Dec; 4(6):498. PubMed ID: 8749577
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.